AI
20/20 Biolabs, Inc. Common Stock (AIDX)
NASDAQ·Healthcare·Medical - Devices
$0.94
+9.30%
Mkt Cap $13.95M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+431.9%
Consensus $5.00 vs current $0.94